Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
RXST
#2805
RxSight, Inc. Common Stock
7.4
8
-1.97%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-1.97%
Aylık değişim
-18.96%
6 aylık değişim
-14.32%
Yıllık değişim
-73.75%
Önceki kapanış
7.6
3
Open
7.4
8
Bid
Ask
Low
7.4
8
High
7.4
8
Hacim
65
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
RXST
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
27.42 M
33.78 M
36.99 M
40.49 M
41.27 M
—
Valuation ratios
Enterprise value
284.09 M
419.82 M
1.35 B
1.38 B
410.05 M
2.24 B
Price to earnings ratio
-3.15
-5.3
-25.99
-48.42
-10.97
-76.02
Price to sales ratio
6.78
7.21
14.18
9.55
3.17
15.81
Price to cash flow ratio
-3.43
-6.01
-30.36
-78.85
27.44
-83.44
Price to book ratio
1.11
3.93
7.87
4.75
1.54
3.21
Enterprise value to EBITDA ratio
-5.82
-7.06
-29.25
-41.28
-9.12
-59.22
Profitability ratios
Return on assets %
0.25
0.44
0.27
0.09
0.12
0.13
Return on equity %
0.35
0.74
0.3
0.1
0.14
0.14
Return on invested capital %
884.61
956.41
613.43
318.63
334.43
257.29
Gross margin %
19.99
43.52
60.36
70.71
76.6
306.97
Operating margin %
233.64
129.21
56.23
26.34
35.84
144.7
EBITDA margin %
-216.05
-121.28
-51.65
-23.81
-33.43
-134.98
Net margin %
215.5
136.22
54.57
19.62
28.96
117.07
Liquidity ratios
Quick ratio
15.19
6.95
7.22
10.5
9.75
45.53
Current ratio
15.92
7.81
8.06
11.36
10.95
50.29
Inventory turnover
2.25
2.42
2.19
2.08
1.17
1.24
Asset turnover
0.12
0.29
0.54
0.56
0.43
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.21
0.27
0
—
—
—
Long term debt to total equity ratio
0.29
0.45
0
—
—
—
Per share metrics
Operating cash flow per share
3.28
2.13
1.21
0.44
0.38
0.38
EBIT per share
-3.87
-2.29
-1.45
-0.95
-1.18
-1.18
EBITDA per share
-3.58
-2.15
-1.34
-0.86
-1.1
-1.1
Total debt per share
—
—
—
—
—
—
Cash per share
11.69
3.82
3.69
6.1
5.58
22.38
Net current asset value per share
12.94
4.86
4.89
7.56
7.04
28.05
Tangible book value per share
10.15
3.25
4.65
7.24
6.75
27.2
Working capital per share
12.13
4.24
4.28
6.89
6.39
25.81
Book value per share
10.15
3.25
4.65
7.24
6.75
27.2
Haberler
Needham, RxSight hissesi için Al tavsiyesini tekrarladı
Needham reiterates Buy on RxSight stock, keeps $13 target
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
Rxsight kazancı $0,32 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
Rxsight earnings beat by $0.32, revenue topped estimates
Alphatec (ATEC) Q4 Earnings and Revenues Beat Estimates
Earnings Preview: Teleflex (TFX) Q4 Earnings Expected to Decline
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
RxSight stock initiated with Market Perform rating by William Blair
RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?
Jefferies, RxSight için hedef fiyatını 11,00 dolardan 11,50 dolara yükseltti